Tech Company Financing Transactions

Repairogen Funding Round

Repairogen closed a $76 thousand investment round on 3/31/2015. Investors included Partnership for New York City Fund .

Transaction Overview

Company Name
Announced On
3/31/2015
Transaction Type
Venture Equity
Amount
$76,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Consumer
Mailing Address
526 Campus Rd. 406 Weill Hall
Ithaca, NY 14853
USA
Phone
Undisclosed
Email Address
Overview
Repairogen uses a patent-pending DNA-repair technology to deliver the most advanced, scientifically proven, skincare and anti-aging cosmetics.
Profile
Repairogen LinkedIn Company Profile
Social Media
Repairogen Company Twitter Account
Company News
Repairogen News
Facebook
Repairogen on Facebook
YouTube
Repairogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Borchetta
  Frank Borchetta LinkedIn Profile  Frank Borchetta Twitter Account  Frank Borchetta News  Frank Borchetta on Facebook
Chief Medical Officer
Gilly Munavalli
  Gilly Munavalli LinkedIn Profile  Gilly Munavalli Twitter Account  Gilly Munavalli News  Gilly Munavalli on Facebook
Chief Scientific Officer
Michael Boice
  Michael Boice LinkedIn Profile  Michael Boice Twitter Account  Michael Boice News  Michael Boice on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2015: Safe Deposit Box Insurance Coverage venture capital transaction
Next: 3/31/2015: Synergis Education venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary